Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers have identified a deficit in contrast perception in people with schizophrenia. According to a ...

Depression impacts an estimated 18 million Americans each year, yet depression screening rarely occurs in the outpatient ...

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers at the University of Barcelona have identified a deficit in contrast perception in people with ...

The convergence of iPSC technology with other innovative approaches, such as gene editing and 3D bioprinting, further expands the scope of applications and opens new avenues for therapeutic ...

Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006, significant progress has ... iPSCs can be used to explore the causes of disease onset and progression, create and test ...

Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006 ... causes of disease onset and progression, create and test new drugs and therapies, and treat previously incurable ...

How we use technology has gone through a paradigm shift already with telemedicine and remote monitoring becoming necessary during the pandemic. There’s a huge opportunity to work collaboratively ...

Biometric and identity verification provider in Africa, Smile ID, has introduced Enhanced SmartSelfie, an upgraded technology designed ... rate in rigorous fraud tests involving advanced methods ...

LB Pharmaceuticals has shared top-line data from a phase 2 schizophrenia trial ... The phase 2 trial represented a key test of that idea. LB Pharma saw statistically significant changes on ...